Table 3.
Comparison of the clinical characteristics of candidates deceased due to COVID-19 in the first versus the second peak of the epidemic
| Candidates deceased due to COVID-19 (n = 60) |
|||
|---|---|---|---|
| First peak (March 1–April 15, 2020) | Second peak (April 16–June 1, 2020) | P | |
| N | 37 (62) | 23 (38) | |
| Male | 25 (67.6) | 18 (78.3) | 0.37 |
| Age, yr | 65.4 ± 8.7 | 58.3 ± 11.8 | 0.04 |
| Cardiovascular disease | 5 (14.7) | 5 (21.7) | 0.5 |
| Diabetes | 16 (44.4) | 13 (56.5) | 0.37 |
| BMI, kg/m2 | 29.1 ± 4.9 | 27.2 ± 4.6 | 0.1 |
| Blood group | 0.82 | ||
| A | 10 (27) | 5 (21.7) | |
| B | 2 (5.4) | 0 (0) | |
| AB | 7 (18.9) | 5 (21.7) | |
| O | 18 (48.6) | 13 (56.5) | |
| Cause of ESRD | 0.4 | ||
| Diabetes | 10 (27) | 11 (47.8) | |
| Glomerulonephritis | 7 (18.9) | 2 (8.7) | |
| Nephroangiosclerosis | 6 (16.2) | 4 (17.4) | |
| Other | 7 (18.9) | 5 (21.7) | |
| Polycystic kidney disease | 4 (10.8) | 0 (0) | |
| Tubulointerstitial nephritis | 3 (8.1) | 1 (4.3) | |
| Previous transplantation | 8 (21.6) | 6 (26.1) | 0.63 |
| Time on dialysis, mo | 47.9 ± 52.6 | 33.3 ± 31.8 | 0.19 |
BMI, body mass index; COVID-19, coronavirus disease 2019; ESRD, end-stage renal disease.
Values are n (%) or mean (± SD), unless otherwise indicated.